- Home
- ADIL vs PAVM Comparison
ADIL vs PAVM Comparison
Compare ADIL & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADIL
- PAVM
- Stock Information
- Founded
- ADIL 2010
- PAVM 2014
- Country
- ADIL United States
- PAVM United States
- Employees
- ADIL N/A
- PAVM N/A
- Industry
- ADIL Biotechnology: Pharmaceutical Preparations
- PAVM Medical/Dental Instruments
- Sector
- ADIL Health Care
- PAVM Health Care
- Exchange
- ADIL Nasdaq
- PAVM Nasdaq
- Market Cap
- ADIL 6.5M
- PAVM 6.7M
- IPO Year
- ADIL 2018
- PAVM 2016
- Fundamental
- Price
- ADIL $0.96
- PAVM $0.65
- Analyst Decision
- ADIL Strong Buy
- PAVM Strong Buy
- Analyst Count
- ADIL 1
- PAVM 1
- Target Price
- ADIL $8.00
- PAVM $19.00
- AVG Volume (30 Days)
- ADIL 86.8K
- PAVM 302.5K
- Earning Date
- ADIL 11-13-2024
- PAVM 11-14-2024
- Dividend Yield
- ADIL N/A
- PAVM N/A
- EPS Growth
- ADIL N/A
- PAVM N/A
- EPS
- ADIL N/A
- PAVM 0.53
- Revenue
- ADIL N/A
- PAVM $4,034,000.00
- Revenue This Year
- ADIL N/A
- PAVM $52.90
- Revenue Next Year
- ADIL N/A
- PAVM $248.84
- P/E Ratio
- ADIL N/A
- PAVM $1.23
- Revenue Growth
- ADIL N/A
- PAVM 166.27
- 52 Week Low
- ADIL $0.77
- PAVM $0.57
- 52 Week High
- ADIL $4.17
- PAVM $3.50
- Technical
- Relative Strength Index (RSI)
- ADIL 37.57
- PAVM 41.81
- Support Level
- ADIL $0.99
- PAVM $0.58
- Resistance Level
- ADIL $1.06
- PAVM $0.67
- Average True Range (ATR)
- ADIL 0.06
- PAVM 0.06
- MACD
- ADIL -0.01
- PAVM 0.02
- Stochastic Oscillator
- ADIL 0.00
- PAVM 38.89
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The Company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.